Get started
Sionna Therapeutics, Inc.Sionna Therapeutics, Inc.Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast

SION chart


Full chart

SION upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪526.40 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−61.69 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪27.05 M‬
Beta (1Y)
−1.17

Employees


Employees (FY)
41
Change (1Y)
+13 +46.43%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.50 M‬ USD

About Sionna Therapeutics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Michael Cloonan
Website
sionnatx.com
Headquarters
Waltham
Founded
2019
FIGI
BBG016X2DC85
Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SION news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as SION.

Frequently Asked Questions


The current price of SION is 12.66 USD — it has increased by 7.88% in the past 24 hours. Watch Sionna Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sionna Therapeutics, Inc. stocks are traded under the ticker SION.
SION stock has risen by 34.62% compared to the previous week, the month change is a −6.94% fall, over the last year Sionna Therapeutics, Inc. has showed a −49.36% decrease.
We've gathered analysts' opinions on Sionna Therapeutics, Inc. future price: according to them, SION price has a max estimate of 45.00 USD and a min estimate of 32.00 USD. Watch SION chart and read a more detailed Sionna Therapeutics, Inc. stock forecast: see what analysts think of Sionna Therapeutics, Inc. and suggest that you do with its stocks.
SION reached its all-time high on Feb 7, 2025 with the price of 25.19 USD, and its all-time low was 7.26 USD and was reached on Apr 11, 2025. View more price dynamics on SION chart.
See other stocks reaching their highest and lowest prices.
SION stock is 8.04% volatile and has beta coefficient of −1.17. Track Sionna Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Sionna Therapeutics, Inc. there?
Today Sionna Therapeutics, Inc. has the market capitalization of ‪577.59 M‬, it has increased by 40.66% over the last week.
Yes, you can track Sionna Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Sionna Therapeutics, Inc. is going to release the next earnings report on May 28, 2025. Keep track of upcoming events with our Earnings Calendar.
SION earnings for the last quarter are −3.38 USD per share, whereas the estimation was −1.28 USD resulting in a −164.75% surprise. The estimated earnings for the next quarter are −0.45 USD per share. See more details about Sionna Therapeutics, Inc. earnings.
Sionna Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SION net income for the last quarter is ‪−15.85 M‬ USD, while the quarter before that showed ‪−11.88 M‬ USD of net income which accounts for −33.45% change. Track more Sionna Therapeutics, Inc. financial stats to get the full picture.
No, SION doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 24, 2025, the company has 41 employees. See our rating of the largest employees — is Sionna Therapeutics, Inc. on this list?
Like other stocks, SION shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sionna Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.